Drug Trial Radar · NCT02469090
Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease
Last checked: Nov 19, 2026Latest source record: Jul 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
141
Actual
Start
Jun 18, 2015
Primary completion
Dec 11, 2017
Study completion Dec 11, 2017
Sponsor
- Lead sponsor
- Sumitomo Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 11, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A 12-week, prospective, multi-center, randomized, double-blind, placebo controlled, Phase 3 study in L-Dopa responsive PD patients with motor fluctuations ("OFF" episodes), designed to determine the efficacy, safety and tolerability of APL-130277.
Conditions
- Parkinson Disease, Off Episodes
Interventions
APL-130277Drug
Use to treat up to 5 "OFF" episodes per day
PlaceboDrug
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Pre-Dose to 30 Minutes Post-Dose in The Movement Disorders Society Unified Parkinson's Disease Rating Scale Part III Motor Examination (MDS-UPDRS Part III) Score at Maintenance Visit 4 (MV4) - Week 12Time frame: At t=0 (just prior to dosing) and t=30 minutes at MV4 (Week 12 of the Maintenance Treatment Phase).
Locations
33 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama, Birmingham
Birmingham, Alabama
Muhammed Ali Parkinson and Movement Disorder CenterBarrow Neurological
Phoenix, Arizona
Movement Disorders Center of Arizona
Scottsdale, Arizona
Mayo Clinic Arizona
Scottsdale, Arizona
The Parkinson's and Movement Disorder Institute
Fountain Valley, California
UC Irvine Health Gottschalk Medical Plaza
Irvine, California
Keck Medical Center at USC
Los Angeles, California
The Research Center of Southern California
Oceanside, California
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Parkinsons Disease and Movement Disorders Center
Boca Raton, Florida
University of Miami, Miller School of Medicine
Miami, Florida
Parkinson's Disease Treatment Center of Southwest Florida
Port Charlotte, Florida
USF Parkinson's Disease and Movement Disorder Center
Tampa, Florida
Emory University Department of Neurology
Atlanta, Georgia
Northwestern University
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center
Winfield, Illinois
Kansas University Medical Center - Department of Neurology
Kansas City, Kansas
University of Kentucky
Lexington, Kentucky
Johns Hopkins University
Baltimore, Maryland
QUEST Research Institute
Farmington Hills, Michigan
Northern Michigan Neurology
Traverse City, Michigan
Henry Ford Hospital
West Bloomfield, Michigan
Columbia University Medical Center - Neurological Institute, Movement Disorders
New York, New York
Raleigh Neurology Associates, P.A.
Raleigh, North Carolina
Wake Forest Baptist Health
Winston-Salem, North Carolina
University of Cincinnati
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma
Jefferson University Hospital Philadelphia
Philadelphia, Pennsylvania
University of Virginia, Adult Neurology
Charlottesville, Virginia
Evergreen Health
Kirkland, Washington
UHN Toronto Western Hospital
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.